Don Sapatkin, Inquirer Staff Writer Posted: Wednesday, January 2, 2013, 3:01 AM The team of researchers from Philadelphia institutions will ask a federal advisory committee to recommend high-dose vaccination for HIV-positive people, said Pablo Tebas, an infectious-diseases physician at the Hospital of the University of Pennsylvania and senior author of the paper in Annals of Internal Medicine. The Food and Drug Administration in late 2009 licensed Fluzone High-Dose, made by Sanofi Pasteur in Swiftwater, Pa., for use in people 65 and older. There was limited research on other groups, such as people with HIV. The elderly and people with compromised immune systems account for the vast majority...
0 Responses to Research supports high-dose flu vaccine for people with HIV